Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.6950 per EA under NDC 68180067511. Its NADAC has been published 437 times since Apr 11, 2018.
FDA first approved this application on Jan 9, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180067511
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA208348FDA Approved
1/9/2018
TE Code
AB
On Market Since
2/9/2018
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 437 times since Apr 11, 2018, and over the history we have for it it has declined 91.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6950 per EA |
|---|---|
| All-time high | $8.1216 (Oct 10, 2018) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $1.5913 |
| Average price | $2.6675 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 437 |
| Tracking since | Apr 11, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.6950 per EA (NDC 68180067511), effective Aug 19, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 91.0%. It has been tracked across 437 weekly CMS publications since Apr 11, 2018.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Apr 11, 2018, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $8.1216 (Oct 10, 2018), with a median of $1.5913 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 68180067511) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.